Japan Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
The Japanese biotechnology market recorded revenues of $30.8 billion in 2023, representing a compound annual growth rate (CAGR) of 11.3% between 2018 and 2023.
The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $13.1 billion, equivalent to 42.7% of the market's overall value.
The Japanese biotechnology market is experiencing growth due to innovation and potential therapeutic developments. Government initiatives are also helping to drive growth in the industry. For instance, in June 2023, the Ministry of Economy, Trade, and Industry of Japan (METI) announced its plans to invest $3 billion to strengthen partnerships with the United States and support the biotech ecosystem.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the Japan biotechnology market by value in 2023?
What will be the size of the Japan biotechnology market in 2028?
What factors are affecting the strength of competition in the Japan biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Japan's biotechnology market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?

8 Company Profiles

8.1. Takeda Pharmaceutical Company Limited
8.2. Astellas Pharma Inc.
8.3. Daiichi Sankyo Co Ltd
8.4. Mitsubishi Tanabe Pharma Corporation

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related Research
10.4. About the Publisher

List of Tables

Table 1: Japan biotechnology industry value: $ million, 2018-23
Table 2: Japan biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: Japan biotechnology industry category segmentation: $ million, 2018-2023
Table 4: Japan biotechnology industry geography segmentation: $ million, 2023
Table 5: Japan biotechnology industry value forecast: $ million, 2023-28
Table 6: Takeda Pharmaceutical Company Limited: key facts
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Astellas Pharma Inc.: key facts
Table 11: Astellas Pharma Inc.: Annual Financial Ratios
Table 12: Astellas Pharma Inc.: Key Employees
Table 13: Daiichi Sankyo Co Ltd: key facts
Table 14: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 15: Daiichi Sankyo Co Ltd: Key Employees
Table 16: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 17: Mitsubishi Tanabe Pharma Corporation: key facts
Table 18: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 19: Japan size of population (million), 2019-23
Table 20: Japan gdp (constant 2005 prices, $ billion), 2019-23
Table 21: Japan gdp (current prices, $ billion), 2019-23
Table 22: Japan inflation, 2019-23
Table 23: Japan consumer price index (absolute), 2019-23
Table 24: Japan exchange rate, 2019-23

List of Figures

Figure 1: Japan biotechnology industry value: $ million, 2018-23
Figure 2: Japan biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: Japan biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Daiichi Sankyo Co Ltd
Mitsubishi Tanabe Pharma Corporation

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€342EUR$350USD£286GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€513EUR$525USD£429GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€684EUR$700USD£572GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Biotechnology Market by Technology (Cell-Based Assays, Chromatography, DNA Sequencing), Application (Bioinformatics, Food & Agriculture, Health) - Cumulative Impact of High Inflation - Forecast 2023-2030

Biotechnology for the Non-Biotechnologist Training Course (December 2-6, 2024)

Asia-Pacific (APAC) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Co-Promotion and Co-Marketing in Pharmaceuticals and Biotechnology 2014-2024

Royalty Rates in Pharmaceutical and Biotechnology Deals